Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

23

Aug 2019

Iconic Therapeutics Signs Ophthalmology Option Agreement

Iconic Therapeutics a private biopharmaceutical company focused on novel therapeutics for serious diseases such as cancer and agerelated macular degeneration today announced that the Company has signed an agreement with Novartis that provides Novartis with an option on Iconics ophthalmology program...

23

Aug 2019

Enable Injections Enters into Strategic Partnership with Genentech, a Member of the Roche Group

Enable Injections Inc Enable a company developing and manufacturing investigational wearable infusion devices for combination products today announced it has entered into a development agreement with Genentech a member of the Roche Group The enFuse under development by Enable will enable patientadmi...

22

Aug 2019

Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China

Innovent Biologics Inc a worldclass biopharmaceutical company that develops and commercializes high quality medicines today announced that it has entered into a licensing agreement with Eli Lilly and Company Lilly for the development and potential commercialization of oxyntomodulin analog OXM in Chi...

22

Aug 2019

Enteris BioPharma and Cara Therapeutics Enter into Licensing Agreement for Peptelligence® to Advance Development of Oral KORSUVA™

Enteris BioPharma Inc a biotechnology company developing innovative drug products built around its proprietary oral peptide delivery technologies today announced its entry into a definitive licensing agreement with Cara Therapeutics for Enteris Peptelligence technology in the ongoing development of...

press releasesRead more...

23

Aug 2019

Themis Bioscience Announces Exclusive License Agreement and Research Collaboration with MSD to Develop Vaccine Candidates

Themis Bioscience today announced a research collaboration and exclusive license agreement with MSD a Merck Co Inc Kenilworth NJ US company for the research and development of vaccine candidates using Themis measles virus based platform known

23

Aug 2019

Seelos Therapeutics Announces FDA Acceptance of IND Application for SLS-005 for Mucopolysaccharidosis Type III (Sanfilippo Syndrome)

Seelos Therapeutics Inc a clinicalstage biopharmaceutical company is pleased to announce the acceptance of the Investigation New Drug IND application for SLS trehalose by the Food and Drug Administration FDA The FDA has advised Seelos that it may proceed with the proposed clinical trial SLS for Muco...

22

Aug 2019

Rfxcel Will Exhibit at CPhI Middle East & Africa, the Largest Pharmaceutical Event in the Region

Rfxcel the global leader in supply chain track and trace solutions will exhibit at this years CPhI Middle East Africa MEA conference in Abu Dhabi United Arab Emirates The company is cultivating business in the region particularly pertaining to new serialization requirements

22

Aug 2019

ROZLYTREK™ (entrectinib), FDA Approved for Hard-to-Treat NTRK Fusion-Positive Tumors, Available at Biologics by McKesson

Biologics by McKesson an independent specialty pharmacy for oncology and other rare and complex therapeutic areas was selected by Genentech as a specialty pharmacy provider for ROZLYTREK entrectinib for the treatment of hardtotreat and rare NTRK fusionpositive tumors

EventsRead more...

29 - 30

Aug 2019

03 - 04

Sep 2019

BioManufacturing 2019

Sheraton Munich Arabellapark Hotel

04 - 06

Sep 2019

3D Tissue Models Summit

Hanson Wade
Hilton Boston Back Bay

04 - 06

Sep 2019

04 - 06

Sep 2019

Advertisements

Meco - 90 years

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

EDITORIAL SECTION

  • STRATEGY

    REDUCTION OF HEALTH COSTS

    Since autumn the first package of costcutting measures in Switzerlands healthcare system is being reviewed One of the measures is the socalled refere...